top of page
Nagourney Cancer Blog


Small Comfort for Inoperable Pancreatic Cancer Patients
Patients never have a second chance to receive first-line therapy, yet first-line therapy offers the best chance of durable remission.

Dr. Robert A. Nagourney, MD
Jun 91 min read


What Medical Oncologists Aren’t Telling You About Chemotherapy
These results confirm that the majority of cancer patients in the US today do not respond to the NCCN guideline therapies that their physici

Dr. Robert A. Nagourney, MD
Apr 83 min read


5 Hidden Truths About Cancer Treatment That Functional Profiling Solves
Your life is too important to rely on statistical averages. Get the personalized approach you deserve.

Dr. Robert A. Nagourney, MD
Mar 123 min read


For Advanced Biliary Tract Cancer Patients, the Path Forward
Biliary tract cancer afflicts 8,000 patients in the US each year. It is separated into intrahepatic and and extrahepatic.

Dr. Robert A. Nagourney, MD
Feb 253 min read


Revolutionizing Breast Cancer Screening: The Promise of Metabolomics
metabolomics are poised to revolutionize breast cancer screening by enhancing diagnostic accuracy and reducing patient discomfort.

Dr. Robert A. Nagourney, MD
Jan 202 min read


For Patients with the Most Advanced Lung Cancers: “Nunquam Cede” (Latin-Never Yield)
I’ve long held that there are no bad cancers, just cancers that we can or cannot treat.

Dr. Robert A. Nagourney, MD
Dec 11, 20243 min read


Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Dr. Robert A. Nagourney, MD
Nov 19, 20243 min read


Metastatic Breast Cancer Claims Another Life
I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.

Dr. Robert A. Nagourney, MD
Sep 26, 20242 min read


Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!
Genomic findings are a first step. They find targets. The question the patient wants to answer is “Can I hit the target?”

Dr. Robert A. Nagourney, MD
Sep 5, 20243 min read


Metastatic or Recurrent Cancer Patients Can’t Afford to Guess
Cancer patients deserve better. Every patient is unique. Their treatment should be as well.

Dr. Robert A. Nagourney, MD
Jul 18, 20243 min read


For Pancreatic Cancer Patients, “the More You Explain It, The More I Don’t Understand It.” -Mark Twain
Even here in the potentially curable
pancreatic cancer patients, there is a great deal of disagreement on the best treatment.

Dr. Robert A. Nagourney, MD
Jun 13, 20242 min read


The Evolving Landscape of Pancreatic Cancer
Nagourney Cancer Institute remains committed to pioneering research and that promise real hope for those affected by pancreatic cancer.

Dr. Robert A. Nagourney, MD
Apr 29, 20242 min read


bottom of page